Sensitivity and Specificity of Multiple Technologies for the Detection of Confirmed Persistently BVDV Infected Cattle from a Feed Yard in South Texas

Authors: Lalitha Peddireddi1, Richard Hesse1, Gregg Hanzlicek1, Jeff Baxter2, Ivan Leyva-Baca2

1Kansas State Veterinary Diagnostic Laboratory, Kansas State University, 2005 Research Park Circle Manhattan, KS 66506

2Animal Health Group at Thermo Fisher Scientific, 2130 Woodward St, Austin, TX 78744, USA

The world leader in serving science

Etiology: Bovine Viral Diarrhea Virus (BVDV)

Bovine Viral Diarrhea Virus (BVDV) is a pathogen belonging to the genus Pestivirus of the family Flaviviridae. It is an enveloped, single-stranded RNA virus.

Economic Relevance: Bovine Viral Diarrhea leads to major economic loss in both beef and dairy industries, estimated to be approximately $2-3 billion annually in the US alone.

History: It was first reported in 1946 in Ithaca, New York, by researchers from Cornell University in a one-cow herd, with subsequent outbreaks of the disease showing morbidity of 33-88% and mortality of 4-8%.

Genome: BVDV has a positive-sense single-stranded RNA genome (ss (+) RNA), approximately 12.3 Kb in size. The genomic RNA contains one open reading frame of about 4000 codons, flanked by two untranslated regions (5'- and 3'-UTR).

Diagram Description: A linear representation of the BVDV genome showing the 5'UTR, Npro, Core, E1, E2, p7, NS2 (NS23), NS3, NS4A, NS4B, NS5A, NS5B, and 3'UTR, indicating structural and non-structural regions.

Citation: Vet. Res. 41 (6) 44 (2010). DOI: 10.1051/vetres/2010016. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any noncommercial medium, provided the original work is properly cited.

Classification of BVDV

Cattle are the natural host of BVDV, but infection has been demonstrated in other species, including sheep, goats, wild ruminants, pigs, bison, alpacas, mouse deer, mountain goats, and white-tailed deer.

The virus is divided into two main genotypes:

Most recently, BVDV-3 or HoBi-like pestivirus has been classified as an atypical pestivirus.

Other pestiviruses include Classical Swine fever and Borders Disease Virus.

Note: More recent data has demonstrated that both genotypes (BVDV-1 and BVDV-2) can cause the same damage at respiratory and reproductive levels.

Further classification based on isolates:

Diagram Description: A phylogenetic tree illustrating the relationships among various pestivirus strains, with distinct branches for BVDV type 1 and BVDV type 2. Microscopic images labeled 'ncp' and 'cp' are also shown.

Citations: Vet. Res. 41 (6) 44 (2010). DOI: 10.1051/vetres/2010016. Open Access article under Creative Commons Attribution-Noncommercial License (http://creativecommons.org/licenses/by-nc/3.0/). Virol J. 2011 Feb 25;8:83. doi: 10.1186/1743-422X-8-83. Copyright Policy - open access http://openi.nlm.nih.gov/index.php.

BVDV Presence and Epidemiology

Presence: BVDV has a world-wide presence. Prevalence of seropositive cattle varies among countries and is influenced by vaccine use and management practices. In the USA, seropositive rates range between 40% and 90%. Unvaccinated herd-level prevalence varies from 28% to 53% depending on the region. PI prevalence is approximately 0.2% in the USA.

Epidemiology: From an epidemiological point of view, BVDV is very adaptable. It employs a combination of strategies to remain in a herd for extended periods. Persistent infection provides a unique ability for BVDV to survive by inducing immune tolerance through evasion of both innate and acquired immunity in utero. Laboratory techniques are the best way to detect the presence of BVDV and distinguish the form of the disease.

BVDV-Persistently Infected (PI) Creation

Diagram Description: A flowchart illustrating the creation of Persistently Infected (PI) BVDV cattle. It depicts pathways starting from insemination, leading to potential embryonic death or return to estrus if the ncp biotype is involved, resulting in persistent infection and immunotolerance. Alternatively, infection can lead to transient infection and seroconversion, or birth of a PI calf. PI calves can develop mucosal disease through mutation from ncp to cp. Transient infection can also result in abortion or malformation.

Citation: Vet. Res. 41 (6) 44 (2010). DOI: 10.1051/vetres/2010016. Open Access article under Creative Commons Attribution-Noncommercial License (http://creativecommons.org/licenses/by-nc/3.0/).

The Impact of BVDV PI Animals on BRD

Although the prevalence of PI-BVDV cattle in the USA is very low, the presence of only one PI-BVDV animal is well documented (Hay et al, 2016) to be a risk factor in feed yards for an increased rate of Bovine Respiratory Disease (BRD), cost of vaccination, antibiotic therapy, and mortality of unresolved BRD infections.

BVDV-PI cattle are more likely to become chronically ill or die than non-BVDV-PI cattle. Also, the probability for initial treatment with respiratory disease was 43% greater for cattle exposed to BVDV-PI cattle in the same pen or an adjoining pen (Loneragan; Journal of the American Veterinary Medical Association, 2005).

Diagram Description: A diagram outlining factors influencing Bovine Respiratory Disease (BRD). Preweaning factors include prenatal nutrition, intake of colostrum, preweaning health, temperament, preshipment management, preconditioning, vaccinations, and nutritional status. Postweaning factors include transportation/marketing stress, commingling, receiving period management, castration/dehorning, implant programs, receiving diet nutrients (energy, protein), minerals (Cu, Se, Zn), vitamins (E, antioxidants), and prophylactic antibiotics. These factors, along with the presence of BVDV (indicated by '?'), influence immunity and ultimately affect feedlot performance, feedlot health, and carcass quality.

BVD: Control and Management

Key strategies for controlling BVDV include:

Study Rationale & Objectives

Rationale: There was a request from the Kansas Farm Bureau in South East Kansas to regulate BVDV in their region by making it a reportable disease. The SNAP BVDV Antigen Test was yielding some discrepant results when compared to testing in VDLs. The application of highly sensitive and specific diagnostic technologies is fundamental to accurately identify those low prevalent PI-BVDV animals for the implementation of control strategies.

Objective: To compare the sensitivity and specificity performance of:

Materials and Methods

Two samplings, with three weeks apart, were performed on previously confirmed PI-BVDV (n=37) and BVDV-negative (n=20) cattle from a feed yard located in South Texas, USA. The feed yard held 24,000 cattle and kept PI-BVDV in a single pen until slaughter time (~n=48).

Diagram Description: A map of the United States highlighting Texas. An image shows cattle ear notching for sample collection. Another image shows a cow with an ear tag.

During the first sampling, five ear notches from each animal were collected in a single day and shipped overnight to the Kansas State Veterinary Diagnostic Laboratory (KSVDL) for processing with the following diagnostic technologies:

Ear Notch No. 1 (Testing Method) 2 (Testing Method) 3 (Testing Method) 4 (Testing Method) 5 (Testing Method)
Sample Prep AM1836 MagMAX™-96 Viral Isolation Kit - - - -
Testing Method VetMAX™ Gold BVDV PI Detection Kit SNAP BVDV Antigen Test ACE BVDV Kit IHC/BVDV RNA Sequencing
Testing Location KSVDL, Manhattan, KS

Two weeks later, resampling of the same set of animals (n=57) was carried out to be tested with IHC and BVDV RNA sequencing as the gold standard methods. True positive or true negative results were determined based on the combined results from at least 1 out of the 2 gold standard methods.

Results

Table 1: Result of the real-time PCR testing, SNAP test, and Antigen Capture ELISA.

Diagnostic technology Gold standard/Tested technology Total count Se (%) Sp (%)
P/P P/N N/P N/N
SNAP 33 3 0 21 57 91.67 100.00
ACE 34 2 0 21 57 94.44 100.00
VetMAX-Gold BVDV PI Detection Kit 36 0 0 21 57 100.00 100.00

Discussion and Conclusions

All of the diagnostic technologies tested in this study offered a good but different level of sensitivity and an equal level of specificity.

However, the real-time PCR technology tested was more sensitive than the antibody-based methods.

The practical implication of using diagnostic technologies with low sensitivity (e.g., 91.67% and 94.44%) with a disease of very low prevalence (0.2%-0.4%) such as PI-BVDV in the US is of significant importance.

Diagram Description: Three flowcharts illustrate the breakdown of a population of 24,000 cattle for each diagnostic test, showing the number of True Positives, False Negatives, False Positives, and True Negatives.

The current study reveals substantial practical differences in diagnostic methods that can be used as management tools in controlling BVDV and ultimately reducing the incidence of BRD.

Acknowledgments

For Veterinary Use Only. For In Vitro Use Only. Regulatory requirements vary by country; products may not be available in your geographic area. © 2017 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries. IDEXX SNAP® is a trademark of IDEXX LtD.

PDF preview unavailable. Download the PDF instead.

ah-wavld-17-presentation-bvdv-methods Microsoft PowerPoint 2010

Related Documents

Preview RNA Reference Guide: Sample Preparation and Purification Solutions | Thermo Fisher Scientific
This comprehensive guide from Thermo Fisher Scientific details advanced solutions for RNA isolation and purification. It covers various technologies including organic extraction, spin columns, and magnetic beads, alongside instruments like KingFisher, Qubit, and NanoDrop. Discover TRIzol, PureLink, MagMAX, Dynabeads, and Cells-to-CT kits for efficient sample preparation in molecular biology research.
Preview TaqPath COVID-19, Flu A/B, RSV Combo Kit Lab Readiness Checklist
A comprehensive checklist from Thermo Fisher Scientific for the Applied Biosystems TaqPath COVID-19, Flu A/B, RSV Combo Kit, detailing required instruments, consumables, and software for SARS-CoV-2, influenza A/B, and RSV detection.
Preview Thermo Fisher Scientific DNA Reference Guide: Sample Preparation and Purification Solutions
A comprehensive guide from Thermo Fisher Scientific detailing DNA sample preparation and purification technologies, including organic extraction, column purification, and magnetic beads, with product information and application tips.
Preview QuantStudio™ 3D Digital PCR System User Guide
User guide for the QuantStudio™ 3D Digital PCR System, detailing its use with compatible instruments, chips, and software for quantitative and qualitative detection of nucleic acid sequences. Includes setup, operation, troubleshooting, and safety information.
Preview RNA Reference Guide: Sample Preparation and Purification Solutions
A comprehensive guide from Thermo Fisher Scientific detailing methods and products for RNA isolation and purification, including TRIzol, MagMAX, PureLink, and Cells-to-CT technologies, for various research applications.
Preview Thermo Fisher Scientific Agriculture Resource Guide for Genomics and Biotechnology
A comprehensive guide from Thermo Fisher Scientific (Applied Biosystems) detailing genomic and molecular biology solutions for plant and animal research in agriculture, covering sequencing, genotyping, gene expression, and more.
Preview Thermo Fisher Scientific Bioprocessing Solutions Catalog
Explore Thermo Fisher Scientific's comprehensive bioprocessing solutions, covering everything from drug development to commercial production. This catalog details single-use technologies, production chemicals, and analytical methods designed to optimize biomanufacturing processes.
Preview Thermo Fisher Connect: Remote Access for Thermal Cyclers - Quick Reference Guide
A quick reference guide on setting up and using Thermo Fisher Connect for remote access and control of SimpliAmp and ProFlex PCR systems. Covers requirements, account creation, firmware upgrades, instrument linking, and remote monitoring via desktop and mobile devices.